Healthcare IT Today

NOVEMBER 6, 2023

” The acquisition follows AllStripes’ $50 million Series B funding round in 2021 and PicnicHealth’s $60 million Series C round in 2022. About AllStripes ‍ Founded in 2017, AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases.

Life Science 95

Life Science Drug Development Patient Experience healthcare technology 95

Healthcare IT Today

NOVEMBER 14, 2022

In 2022, AngelEye is on pace to deliver nearly 10 million virtual bedside visits. Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market. Originally announced November 10th, 2022. About AngelEye Health.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development.

BioTech 88

BioTech Life Science Leadership Drug Development 88

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

The Explosive Growth of Generative AI in Healthcare Market by 2032 According to a report from finance.yahoo.com, the global market for generative AI in healthcare, which was estimated at $1,070 million in 2022, is forecasted to surge to around $21,740 million by the year 2032. What are the benefits of AI in drug development?

Mental health 40

Mental health Health Data Drug Development Patient Experience 40